FangyuLei/tatqa huggingface dataset:
December 31,
December 31,
2018
2019
Balance at beginning of year
(12,749)
(13,364)
Charged to cost of sales
(2,958)
(4,748)
Reversals
723
915
Utilization of the provision
1,978
4,994
Foreign currency translation effect
(358)
(324)
Balance at end of year
(13,364)
(12,527)
note 8 .
inventories .
the changes in the allowance for obsolescence are as follows : .
on december 31 2019 our allowance for inventory obsolescence amounted to € 12527 which is 6 .
7 % of total inventory .
the major part of the allowance is related to components and raw materials .
the additions for the years 2018 and 2019 mainly relate to inventory items which ceased to be used due to technological developments and design changes which resulted in obsolescence of certain parts .
the cost of inventories recognized as costs and included in cost of sales amounted to € 510 .
2 million -2018 : € 365 .
8 million .

Question: Which component caused the greatest increase in allowance for inventory obsolescence in 2019?
Answer: Charged to cost of sales
Name and address of Beneficial Owner
Amount of Beneficial Ownership
Percent of Beneficial Ownership
Garo H. Armen (1)
4,741,323
36%
Robert B. Stein (1)
502,500
4%
Khalil Barrage (1)
380,000
3%
Alexander K. Arrow (1)
671,799
6%
Larry N. Feinberg 808 North St., Greenwich, CT 06831
800,000
7%
Brian J. Corvese (1)
145,000
1%
David A. Lovejoy
668,037
6%
Josh Silverman (1)
140,000
1%
Strategic Bio Partners LLC (10) 777 Third Avenue 30th Floor New York, NY 10017
1,895,945
17%
All directors and executive officers as a group (6 persons)
6,580,622
44%
security ownership of certain beneficial owners and management .
the following table summarizes the beneficial owners of more than 5 % of the company ’ s voting securities and the securities of the company beneficially owned by the company ’ s directors and officers as of april 27 2020 .

Question: What is the amount and percent of beneficial ownership owned by Robert B. Stein?
Answer: 502,500 4%
As reported December 31, 2018
Effect of ASC 606 adoption
Amounts without adoption of ASC 606 December 31, 2018
Trade receivables, net
$172.3
$6.9
$179.2
Prepaid expenses and other current assets
67.3
(14.4)
52.9
Receivables from related parties
6.2
4.8
11.0
Computer software, net
405.6
(3.7)
401.9
Deferred contract costs, net
161.3
(17.2)
144.1
Other non-current assets
125.6
(7.0)
118.6
Total assets
3,653.4
(30.6)
3,622.8
Deferred revenues (current)
52.9
4.1
57.0
Deferred revenues (non-current)
106.8
(4.3)
102.5
Deferred income taxes
220.9
(8.1)
212.8
Total liabilities
1,866.9
(8.3)
1,858.6
Retained earnings
381.1
(22.3)
358.8
Total equity
1,786.5
(22.3)
1,764.2
Total liabilities and equity
3,653.4
(30.6)
3,622.8
effect of asc 606 as of december 31 2018 and for the year ended december 31 2018 .
the following table summarizes the effect of adopting asc 606 on our consolidated balance sheet -in millions : .

Question: What was the difference in the reported amount in 2018 between net computer software and net deferred contract costs?
Answer: 244.3
Year Ended March 31,
Year Ended March 31,
Year Ended March 31,
2019
2018
2017
Cost of sales (1)
$14.9
$13.8
$18.7
Research and development
72.0
42.5
46.8
Selling, general and administrative
62.3
36.9
62.6
Special (income) charges and other, net
17.2
—
—
Pre-tax effect of share-based compensation
166.4
93.2
128.1
Income tax benefit
35.5
28.3
44.2
Net income effect of share-based compensation
$130.9
$64.9
$83.9
note 16 .
share-based compensation .
share-based compensation expense .
the following table presents the details of the company ' s share-based compensation expense -in millions : .
-1 during the year ended march 31 2019 $ 17 .
2 million of share-based compensation expense was capitalized to inventory and $ 14 .
9 million of previously capitalized share-based compensation expense in inventory was sold .
during the year ended march 31 2018 $ 11 .
9 million of share-based compensation expense was capitalized to inventory and $ 13 .
8 million of previously capitalized share-based compensation expense in inventory that was sold .
during the year ended march 31 2017 $ 11 .
3 million of share-based compensation expense was capitalized to inventory .
the amount of sharebased compensation included in cost of sales during fiscal 2017 included $ 14 .
5 million of previously capitalized sharebased compensation expense in inventory was sold and $ 4 .
2 million of share-based compensation expense related to the company ' s acquisition of atmel that was not previously capitalized into inventory .
the amount of unearned share-based compensation currently estimated to be expensed in the remainder of fiscal 2020 through fiscal 2024 related to unvested share-based payment awards at march 31 2019 is $ 253 .
4 million .
the weighted average period over which the unearned share-based compensation is expected to be recognized is approximately 1 .
88 years .

Question: What was the change in the cost of sales between 2017 and 2018?
Answer: -4.9
Capital expenditures 2017–2019
Capital expenditures 2017–2019
Capital expenditures 2017–2019
Capital expenditures 2017–2019
SEK billion
2019
2018
2017
Capital expenditures
5.1
4.0
3.9
Of which in Sweden
2.0
1.3
1.5
Share of annual sales
2.3%
1.9%
1.9%
capital expenditures .
for 2019 capital expenditure was sek 5 .
1 -4 .
0 billion representing 2 .
3 % of sales .
expenditures are largely related to test sites and equipment for r & d network operation centers and manufacturing and repair operations .
the increase in 2019 was mainly due to investments in 5g test equipment .
annual capital expenditures are normally around 2 % of sales .
this corresponds to the needs for keeping and maintaining the current capacity level .
the board of directors reviews the company ’ s investment plans and proposals .
as of december 31 2019 no material land buildings machinery or equipment were pledged as collateral for outstanding indebtedness .

Question: Why was there an increase in capital expenditure in 2019?
Answer: investments in 5G test equipment
($ in million)
($ in million)
($ in million)
($ in million)
For the year ended December 31:
2019
2018
Yr.-to-Yr. Percent Change
Total consolidated research, development and engineering
$5,989
$5,379
11.3%
Non-operating adjustment
Acquisition-related charges
(53)
-
NM
Operating (non-GAAP) research, development and engineering
$5,936
$5,379
10.4%
research development and engineering expense .
nm — not meaningful .
research development and engineering -rd & e expense was 7 .
8 percent of revenue in 2019 and 6 .
8 percent of revenue in 2018 .
rd & e expense increased 11 .
3 percent in 2019 versus 2018 primarily driven by : • higher spending -11 points including investment in the z15 and red hat spending in the second half of 2019 -8 points ; and • higher acquisition-related charges associated with the red hat transaction -1 point ; partially offset by • the effects of currency -1 point .
operating -non-gaap expense increased 10 .
4 percent year to year primarily driven by the same factors excluding the acquisition-related charges associated with the red hat transaction .

Question: What percentage of total revenue was Research, development and engineering (RD&E) expenses?
Answer: Research, development and engineering (RD&E) expense was 7.8 percent of revenue in 2019 and 6.8 percent of revenue in 2018.
Years Ended
Dec 28, 2019
Dec 29, 2018
Dec 30, 2017
Statutory federal income tax rate
21.0%
21.0%
35.0%
Increase (reduction) in rate resulting from:
Non-U.S. income taxed at different rates
(3.7)
(3.6)
(7.6)
Research and development tax credits
(2.3)
(2.7)
(2.3)
Domestic manufacturing deduction benefit
—
—
(1.3)
Foreign derived intangible income benefit
(3.2)
(3.7)
—
Tax Reform
—
(1.3)
26.8
ISecG divestiture
—
—
3.3
Other
0.7
(0.1)
(1.1)
Effective tax rate
12.5%
9.7%
52.8%
the difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes -effective tax rate for each period was as follows : .
the majority of the increase in our effective tax rate in 2019 compared to 2018 was driven by one-time benefits that occurred in 2018 .
the majority of the decrease in our effective tax rate in 2018 compared to 2017 resulted from initial tax expense from tax reform and the tax impacts from the isecg divestiture that we had in 2017 but not in 2018 .
the reduction of the u .
s .
statutory rate combined with the net impact of the enactment or repeal of specific tax law provisions through tax reform drove the remaining decrease in our effective tax rate in 2018 .
we derive the effective tax rate benefit attributed to non-u .
s .
income taxed at different rates primarily from our operations in china hong kong ireland and israel .
the statutory tax rates in these jurisdictions range from 12 .
5 % to 25 .
0 % .
in addition we are subject to reduced tax rates in china and israel as long as we conduct certain eligible activities and make certain capital investments .
these conditional reduced tax rates expire at various dates through 2026 and we expect to apply for renewals upon expiration .

Question: What does the table show?
Answer: The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period
December 31, 2019
December 31, 2018
Accounting
$36,161
$52,365
Research and development
650,584
137,114
Legal
15,273
32,161
Other
163,029
10,048
Total
$865,047
$231,688
note 4 - accounts payable and accrued expenses .
accounts payable and accrued expenses consist of the following at : .
on october 1 2019 the company entered into an agreement with a consultant for toxicology studies .
the consultant quoted a commitment of approximately $ 988000 as an estimate for the study .
50 % of the total price is to be paid upon the signing of the agreement 35 % of the total price is to be upon completion of the in-life study and the remaining 15 % of the total price is to be paid upon the issuance of the report .
if the company cancels the study the company will be required to pay a cancelation fee .
if the cancelation happens prior to the arrival of the test animals then the company will need to pay between 20 % and 50 % of the animal fees depending on when the cancellation happens .
if the cancellation occurs after the animals arrive but before the study begins then the company will be responsible for paying 50 % of the protocol price plus a fee of $ 7000 per room / week for animal husbandry until the animals can be relocated or disposed of .
if the company cancels the study after it has begun then the company will need to pay any fees for procured items for the study and any nonrecoverable expenses incurred by the vendor .
as of december 31 2019 the company has paid $ 0 and there is a balance of $ 493905 due .

Question: What is the quoted consultation fees for the toxicology studies?
Answer: $988,000
Payments Due By Period
Payments Due By Period
Payments Due By Period
Payments Due By Period
(Dollars in Millions)
Total
Less than 1 year
1-3 years
3-5 years
More than 5 years
Capital Leases
$1.7
$0.6
$0.9
$0.2
$—
Operating Leases
34.2
7.8
10.5
7.5
8.4
Debt (1)
295.5
15.7
28.8
247.7
3.3
Estimated Interest on Debt (2)
46.8
11.7
20.7
14.2
0.2
Deferred Compensation
8.5
1.2
3.2
1.6
2.5
Total
$386.7
$37.0
$64.1
$271.2
$14.4
contractual obligations .
the following table summarizes contractual obligations and commitments as of april 27 2019 : .
-1 assumes the outstanding borrowings under the revolving credit facility will be repaid upon maturity of the credit agreement in september 2023 .
-2 amounts represent estimated contractual interest payments on outstanding debt .
interest rates in effect as of april 27 2019 are used for floating-rate debt .
we enter into agreements with suppliers to assist us in meeting our customers ' production needs .
these agreements vary as to duration and quantity commitments .
historically most have been short-term agreements which do not provide for minimum purchases or are requirements-based contracts .

Question: What was the difference in the capital leases due from less than 1 year to those due in 1-3 years?
Answer: 0.3
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
(in thousands of U.S. dollars, except calendar-ship-days)
2019
2018
Revenues
943,917
776,493
Voyage expenses
(402,294)
(381,306)
Vessel operating expenses
(208,601)
(209,131)
Time-charter hire expense
(43,189)
(19,538)
Depreciation and amortization
(124,002)
(118,514)
General and administrative expenses
(36,404)
(39,775)
Write-down and loss on sale of vessels
(5,544)
170
Restructuring charges
—
(1,195)
Income from vessel operations
123,883
7,204
Equity income
2,345
1,220
Calendar-Ship-Days (1)
Conventional Tankers
22,350
21,226
operating results – teekay tankers .
the following table compares teekay tankers ’ operating results equity income and number of calendar-ship-days for its vessels for 2019 and 2018 .
-1 calendar-ship-days presented relate to owned and in-chartered consolidated vessels .
teekay tankers ' income from vessel operations increased to $ 123 .
9 million in 2019 compared to $ 7 .
2 million in 2018 primarily as a result of : • an increase of $ 129 .
3 million due to higher overall average realized spot tanker rates earned by teekay tankers ' suezmax aframax and lr2 product tankers ; • an increase of $ 3 .
5 million due to improved net results from teekay tankers ' full service lightering -or fsl activities from more voyage days and higher realized spot rates earned ; .
• an increase of $ 3 .
4 million resulting from lower general and administrative expenses primarily due to non-recurring project expenses incurred in 2018 ; • a net increase of $ 2 .
3 million primarily due to the delivery of three aframax and two lr2 chartered-in tankers in late 2018 and throughout 2019 partially offset by the redeliveries of various in-chartered tankers to their owners in the second and third quarters of 2018 ; and • an increase of $ 1 .
2 million as a result of restructuring charge incurred in the prior year ; .
partially offset by .
• a decrease of $ 10 .
2 million due to a higher number of off-hire days in 2019 resulting from dry dockings and higher off-hire bunker expenses compared to the prior year ; • a decrease of $ 6 .
9 million due to lower revenues and loss on the sale of one suezmax tanker in 2019 and the write-down of two suezmax tankers that were classified as held for sale at december 31 2019 ; and • a decrease of $ 6 .
4 million due to the amortization of first dry dockings for various former tanker investments ltd .
-or til vessels subsequent to teekay tankers ' acquisition of til in late 2017 .
equity income increased to $ 2 .
3 million in 2019 from $ 1 .
2 million in 2018 primarily due to higher earnings recognized in 2019 from the high-q investment ltd .
joint venture as a result of higher spot rates earned in 2019 .

Question: What is the value of Conventional Tankers in 2019?
Answer: 22,350
Years Ended December 31,
Years Ended December 31,
Years Ended December 31,
2019
2018
2017
Net earnings
$36,146
$46,532
$14,448
Other comprehensive earnings (loss):
Changes in fair market value of derivatives, net of tax
(509)
795
110
Changes in unrealized pension cost, net of tax
6,439
(1,830)
13,687
Cumulative translation adjustment, net of tax
83
(311)
437
Other comprehensive earnings (loss)
$6,013
$(1,346)
$14,234
Comprehensive earnings
$42,159
$45,186
$28,682
cts corporation and subsidiaries consolidated statements of comprehensive earnings -in thousands .
the accompanying notes are an integral part of the consolidated financial statements .

Question: What were the net earnings in 2019?
Answer: 36,146
Year Ended
Year Ended
Year Ended
April 26, 2019
April 27, 2018
April 28, 2017
Dividends per share declared
$ 1.60
$ 0.80
$ 0.76
Dividend payments allocated to additional paid-in capital
$ 403
$ 106
$ 88
Dividend payments allocated to retained earnings (accumulated deficit)
$ —
$ 108
$ 120
dividends .
the following is a summary of our fiscal 2019 2018 and 2017 activities related to dividends on our common stock -in millions except per share amounts .
on may 22 2019 we declared a cash dividend of $ 0 .
48 per share of common stock payable on july 24 2019 to shareholders of record as of the close of business on july 5 2019 .
the timing and amount of future dividends will depend on market conditions corporate business and financial considerations and regulatory requirements .
all dividends declared have been determined by the company to be legally authorized under the laws of the state in which we are incorporated .

Question: What do the timing and amount of future dividends depend on?
Answer: market conditions, corporate business and financial considerations and regulatory requirements.
December 31,
December 31,
2019
2018
Cash and cash equivalents
$259,067
$256,947
Restricted cash included in other assets
304
304
Cash, cash equivalents and restricted cash shown in the statement of cash flows
$259,371
$257,251
cash cash equivalents and restricted cash .
as of december 31 2019 the company had $ 259 .
1 million of cash and cash equivalents .
cash and cash equivalents include liquid investments primarily money market funds with maturities of less than 90 days at the time of purchase .
management determines the appropriate classification of its investments at the time of purchase and at each balance sheet date .
as of december 31 2019 and december 31 2018 the company had restricted cash of $ 0 .
3 million representing the amount pledged as collateral to the issuer of a standby letter of credit -the “ lc ” .
the lc which expires in august 2021 has been provided as a guaranty to the lessor of our corporate offices .
the following table provides a reconciliation of cash cash equivalents and restricted cash reported within the consolidated balance sheet to the consolidated statement of cash flows -in thousands : .

Question: What are the respective cash, cash equivalents and restricted cash shown in the statement of cash flows in 2018 and 2019?
Answer: $257,251 $259,371
Fiscal years ended July 31,
Fiscal years ended July 31,
2019
2018
Net cash provided by operating activities
$116,126
$140,459
Net cash used for capital expenditures
(48,857)
(12,011)
Free cash flow
$67,269
$128,448
free cash flow .
we monitor our free cash flow as a key measure of our overall business performance which enables us to analyze our financial performance without the effects of certain non-cash items such as depreciation amortization and stock-based compensation expenses .
additionally free cash flow takes into account the impact of changes in deferred revenue which reflects the receipt of cash payment for products before they are recognized as revenue and unbilled accounts receivable which reflects revenue that has been recognized that has yet to be invoiced to our customers .
our net cash provided by -used in operating activities is significantly impacted by the timing of invoicing and collections of accounts receivable the timing and amount of annual bonus payments as well as payroll and tax payments .
our capital expenditures consisted of purchases of property and equipment most of which were computer hardware software capitalized software development costs and leasehold improvements .
in fiscal year 2019 free cash flow was impacted by $ 23 .
6 million related to the build out and furnishing of our new corporate headquarters in san mateo california .
for a further discussion of our operating cash flows see “ liquidity and capital resources - cash flows .
” -in thousands .

Question: What does free cash flow take into account?
Answer: the impact of changes in deferred revenue, which reflects the receipt of cash payment for products before they are recognized as revenue, and unbilled accounts receivable, which reflects revenue that has been recognized that has yet to be invoiced to our customers.
($ in millions)
($ in millions)
($ in millions)
At December 31:
2019
2018
Total company debt
$62,899
$45,812
Total Global Financing segment debt
$24,727
$31,227
Debt to support external clients
21,487
27,536
Debt to support internal clients
3,239
3,690
Non-Global Financing debt
38,173
14,585
debt .
our funding requirements are continually monitored and we execute our strategies to manage the overall asset and liability profile .
additionally we maintain sufficient flexibility to access global funding sources as needed .
total debt of $ 62899 million increased $ 17087 million from december 31 2018 driven by issuances of $ 32415 million ; partially offset by debt maturities of $ 12673 million and a decrease in commercial paper of $ 2691 million .
non-global financing debt of $ 38173 million increased $ 23587 million from prior year-end levels primarily driven by issuances to fund the red hat acquisition .
global financing debt of $ 24727 million decreased $ 6500 million from december 31 2018 primarily due to the wind down of oem it commercial financing operations .
global financing provides financing predominantly for ibm ’ s external client assets as well as for assets under contract by other ibm units .
these assets primarily for gts generate long-term stable revenue streams similar to the global financing asset portfolio .
based on their attributes these gts assets are leveraged with the balance of the global financing asset base .
the debt used to fund global financing assets is composed of intercompany loans and external debt .
total debt changes generally correspond with the level of client and commercial financing receivables the level of cash and cash equivalents the change in intercompany and external payables and the change in intercompany investment from ibm .
the terms of the intercompany loans are set by the company to substantially match the term currency and interest rate variability underlying the financing receivable and are based on arm ’ s-length pricing .
the global financing debt-to-equity ratio remained at 9 to 1 at december 31 2019 .
as previously stated we measure global financing as a stand-alone entity and accordingly interest expense relating to debt supporting global financing ’ s external client and internal business is included in the “ global financing results of operations ” and in note d “ segments .
” in the consolidated income statement the external debt-related interest expense supporting global financing ’ s internal financing to ibm is reclassified from cost of financing to interest expense .

Question: What was the increase in the Global Financing debt from 2018?
Answer: $6,500 million